The document discusses Jeffrey Epstein's support for research into the late onset of Alzheimer's Disease. It highlights new findings by researchers from Mount Sinai Hospital, the Icelandic Heart Association, Sage Bionetworks, and Merck Research Laboratories, which identify a cluster of genes related to brain inflammation as playing a role in the disease. The research focuses on the TREM2-TYROBP pathway and its potential as a target for new therapies. Jeffrey Epstein's involvement in science philanthropy and his support for mathematical models in research are also noted.
documents/EFTA00655621.pdf
{}